Suppr超能文献

口服胰蛋白酶抑制剂对四氧嘧啶糖尿病大鼠外分泌和内分泌胰腺功能的改善作用。

Oral trypsin-inhibitor-induced improvement of the exocrine and endocrine pancreatic functions in alloxan diabetic rats.

作者信息

Ihse I, Lundquist I, Arnesjö B

出版信息

Scand J Gastroenterol. 1976;11(4):363-8.

PMID:779003
Abstract

Studies are presented dealing with the effect on the exocrine and endocrine pancreas of long-term oral trypsin inhibitor administration to alloxan diabetic rats. Three categories of rats were used: a) normal rats, b) alloxan diabetic rats, and c) alloxan diabetic rats treated with the trypsin inhibitor. 1. The concentration of amylase in both pancreas and intestinal contents were markedly decreased in alloxan diabetic rats as compared with normal rats, whereas the concentrations of lipase and trypsin(ogen) were practically unaffected by the diabetic state. 2. Trypsin inhibitor treatment of diabetic rats enhanced the concentrations of both amylase, trypsin(ogen), and lipase in pancreas and intestinal contents when compared with untreated diabetic controls. 3. Alloxan diabetic rats treated with trypsin inhibitor displayed an increased weight gain, increased pancreatic weight, and increased pancreatic protein concentration as compared with the untreated diabetic controls. 4. Alloxan diabetic rats treated for 3 or 5 weeks with the trypsin inhibitor were found to have decreased basal blood glucose levels and an increased plasma insulin: blood glucose ratio as compared to the untreated diabetic controls. 5. There was no apparent difference in the glucose elimination rate after I.V. glucose loads in diabetic rats given trypsin inhibitor and their diabetic controls. However, the insulin secretory response to the glucose stimulus was slightly improved in the trypsin inhibitor group. 6. Alloxan diabetic rats treated with trypsin inhibitor had an increased total pancreatic insulin content compared with their diabetic controls. It is concluded that long-term daily treatment with oral trypsin inhibitor in alloxan diabetic rats increased enzyme production and secretion in the exocrine pancreas, and produced an improvement of the diabetic condition of the animals. This improvement might partly be due to an increased pancreatic content and secretion of insulin.

摘要

本文呈现了关于长期给四氧嘧啶糖尿病大鼠口服胰蛋白酶抑制剂对其外分泌和内分泌胰腺影响的研究。使用了三类大鼠:a)正常大鼠,b)四氧嘧啶糖尿病大鼠,c)用胰蛋白酶抑制剂治疗的四氧嘧啶糖尿病大鼠。1. 与正常大鼠相比,四氧嘧啶糖尿病大鼠胰腺和肠内容物中的淀粉酶浓度显著降低,而脂肪酶和胰蛋白酶(原)的浓度实际上不受糖尿病状态的影响。2. 与未治疗的糖尿病对照组相比,用胰蛋白酶抑制剂治疗糖尿病大鼠可提高胰腺和肠内容物中淀粉酶、胰蛋白酶(原)和脂肪酶的浓度。3. 与未治疗的糖尿病对照组相比,用胰蛋白酶抑制剂治疗的四氧嘧啶糖尿病大鼠体重增加、胰腺重量增加且胰腺蛋白浓度增加。4. 发现用胰蛋白酶抑制剂治疗3或5周的四氧嘧啶糖尿病大鼠与未治疗的糖尿病对照组相比,基础血糖水平降低且血浆胰岛素:血糖比值增加。5. 给予胰蛋白酶抑制剂的糖尿病大鼠和其糖尿病对照组在静脉注射葡萄糖负荷后的葡萄糖清除率没有明显差异。然而,胰蛋白酶抑制剂组对葡萄糖刺激的胰岛素分泌反应略有改善。6. 与糖尿病对照组相比,用胰蛋白酶抑制剂治疗的四氧嘧啶糖尿病大鼠胰腺胰岛素总含量增加。得出结论,在四氧嘧啶糖尿病大鼠中每日长期口服胰蛋白酶抑制剂可增加外分泌胰腺中的酶产生和分泌,并改善动物的糖尿病状况。这种改善可能部分归因于胰腺胰岛素含量和分泌的增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验